Follow Us
© 2026 Arizent. All rights reserved.
In the world of pharmacy benefit management programs things are about to get narrower, possibly a lot narrower. Henry Loubet is chief strategy officer at Keenan, a large brokerage in California and one of the biggest in the nation, who says there are two trends at the forefront for PBMs: narrower networks and narrower drug options.
Loubet’s firm already has a narrow network option, as many PBMs do, where clients are offered the opportunity to have fewer retail pharmacies for their employees.
For reprint and licensing requests for this article, click here.
Collaboration between employers, brokers and third-party administrators will be essential to developing customized, cost-effective and employee-friendly solutions.
Employers are under pressure to keep benefits competitive while controlling costs, driving new scrutiny of PBMs, hospital prices and GLP-1 coverage for 2027.
At a time of never-ending health benefit cost increases and fiduciary lawsuits, it has never been more important to ensure that claims are paid correctly.
Rising use of the weight-loss drug is fueling the fastest health plan cost growth in a decade and a half, forcing employers to rethink coverage strategies and cost management.
The practical value of a guarantee depends heavily on the contract terms that sit behind the headline.
